SEC Comment Letter 0000000000-25-000896 to Lexaria Bioscience Corp. (LEXX, LEXXW) (CIK 0001348362) (LEXX)
Lexaria Bioscience Corp. (LEXX, LEXXW) (CIK 0001348362)
Date: Jan. 28, 2025 · CIK: 0001348362 · Accession: 0000000000-25-000896
AI Filing Summary & Sentiment
File numbers found in text: 333-284407
Letter
January 28, 2025 Richard Christopher Chief Executive Officer Lexaria Bioscience Corp. #100 - 740 McCurdy Road Kelowna, British Columbia V1X 2P7 Re:Lexaria Bioscience Corp. Registration Statement on Form S-3 Filed January 22, 2025 File No. 333-284407 Dear Richard Christopher: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Avital Perlman, Esq.
Show Raw Text
January 28, 2025
Richard Christopher
Chief Executive Officer
Lexaria Bioscience Corp.
#100 - 740 McCurdy Road
Kelowna, British Columbia V1X 2P7
Re:Lexaria Bioscience Corp.
Registration Statement on Form S-3
Filed January 22, 2025
File No. 333-284407
Dear Richard Christopher:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Avital Perlman, Esq.